Bloomberg
GLP-1 Craze Fuels Protein-Powder Maker Glanbia’s Share Rally
The boom in GLP-1 weight-loss drugs is boosting demand for protein supplements and driving a rally in the stock of Glanbia Plc, a maker of nutrition products popular with gym enthusiasts and athletes.
View original source — Bloomberg ↗
Related stories
The Guardian
TechnologyJun 9, 2026 · 1 min
Whey protein shortage looms as use of weight-loss drugs fuels global demand
The Guardian
MarketWatch
BusinessJun 7, 2026 · 1 min
The Wegovy pill is still dominating the GLP-1 pill market
MarketWatch
Financial Times
BusinessJun 8, 2026 · 1 min
AstraZeneca advances weight-loss pill to take aim at obesity leaders
Financial Times
MarketWatch
BusinessJun 8, 2026 · 1 min
Eli Lilly stock jumps after late-stage trial of next-generation weight-loss drug
MarketWatch